Ipamorelin: A Research Reference
Ipamorelin: A Research Reference
Ipamorelin is a synthetic pentapeptide widely catalogued in research peptide supply. At five residues it is among the smaller peptides in common laboratory circulation, and its compact structure makes it a useful contrast to the large GRF-family peptides frequently discussed alongside it. This reference covers its chemical identity, structural features and analytical characterisation.
This article addresses chemistry and analysis only. No use of any kind is described or implied.
Chemical identity
Ipamorelin carries CAS registry number 170851-70-4. Its molecular formula is C38H49N9O5, corresponding to a molecular weight of approximately 711.85 g/mol. Unlike many research peptides it is generally catalogued under a single name, which removes one common source of cross-referencing error.
The comparatively low molecular weight is worth noting. At roughly 712 g/mol, Ipamorelin is around one seventh the mass of Tesamorelin and roughly one fifth that of CJC-1295 without DAC. This has direct practical consequences for analysis, since mass spectrometric behaviour, chromatographic retention and detection sensitivity all vary with molecular size.
Structural features
Ipamorelin is a pentapeptide — a chain of five amino acid residues. What distinguishes it structurally from many synthetic peptides is its incorporation of unnatural and D-configuration amino acid residues rather than relying solely on the twenty standard L-amino acids.
Residues in the D-configuration are stereoisomers of their naturally occurring L-counterparts. Their inclusion is a deliberate synthetic choice: peptide bonds adjacent to D-residues are markedly more resistant to enzymatic cleavage, which alters the molecule’s stability profile under analytical conditions. Similarly, non-proteinogenic residues such as aminoisobutyric acid constrain the peptide backbone conformation in ways that standard residues cannot.
For analytical work this matters because stereochemistry is not detectable by mass spectrometry alone. A D-residue and its L-counterpart have identical mass. Distinguishing them requires chiral chromatographic methods or comparison against a reference standard with established retention behaviour — one of several reasons why supplier documentation should specify the analytical method used, not merely a purity percentage.
Synthesis considerations
Short peptides are generally more straightforward to synthesise than long ones, simply because fewer coupling steps means fewer opportunities for error to accumulate. A five-residue chain requires four peptide bond formations, against forty-three for a 44-residue peptide.
That said, incorporating unnatural residues introduces its own difficulties. Sterically hindered residues couple less efficiently than standard ones, and may require extended reaction times or more aggressive coupling reagents. The resulting impurity profile differs in character from that of a conventional peptide — deletion sequences remain possible, but so do incomplete couplings at the hindered positions specifically.
Analytical verification
Research-grade Ipamorelin is typically specified at greater than 98% purity by HPLC, with identity confirmed by LC-MS. At 711.85 g/mol the molecule falls comfortably within the range where mass spectrometry gives a clean, readily interpreted result, generally as a singly or doubly charged species.
Purity by HPLC is reported as a percentage of total peak area at a specified detection wavelength, most commonly 214 nm, where the peptide bond itself absorbs. It is worth understanding that this figure is method-dependent: the same material analysed with a different gradient, column or wavelength may return a slightly different number. This is why a Certificate of Analysis states the method alongside the result.
Physical form and storage chemistry
Ipamorelin is supplied as a lyophilised powder in a sealed glass research vial, typically white to off-white in appearance. In the dried state the principal degradation pathways available to peptides — hydrolysis, deamidation, oxidation of susceptible residues — proceed far more slowly than in solution, since water is largely absent and molecular mobility is low.
Temperature and moisture ingress are the two variables most relevant to long-term stability of lyophilised material. Sealed vials protect against the latter; storage conditions address the former.
Batch variation and documentation
Every synthesis run is a separate event. Coupling efficiencies vary, purification fractions are pooled by human judgement against a chromatogram, and lyophilisation cycles differ in small ways. Two batches of the same peptide from the same manufacturer are therefore similar rather than identical, and the analytical documentation is what records the difference.
This is why a Certificate of Analysis is batch-specific and why the batch identifier matters as much as the figures on the page. A purity result from a previous batch describes material that no longer exists.
For a compound like Ipamorelin, with its unnatural and D-configuration residues, there is an additional reason to attend to the method statement rather than the number alone. A method that establishes chemical purity does not necessarily establish stereochemical integrity, and the two are different claims.
Comparison within the catalogue
Ipamorelin is frequently discussed alongside the GRF-family peptides, and the structural contrast is instructive. Where GRF analogues are long chains built from standard residues, Ipamorelin is a short chain built partly from non-standard ones. These are two quite different approaches to designing a stable synthetic peptide: one relies on reproducing a large natural sequence, the other on making a small sequence resistant to breakdown through deliberate use of unnatural building blocks.
The analytical consequence is that they present entirely different problems. A 44-residue peptide is hard to synthesise cleanly and easy to detect; a five-residue peptide with hindered unnatural residues is comparatively easy to synthesise but raises questions of stereochemistry that mass-based methods cannot answer.
Corix Labs supplies Ipamorelin 10mg as a single-compound lyophilised preparation, and also as a component of a blended vial with CJC-1295 without DAC.
Corix Labs publishes analytical documentation for its research materials. See third-party testing reports for further detail on how batches are verified.
All materials referenced in this article are supplied strictly for laboratory research and analytical use. They are not licensed medicines and are not sold for use in humans or animals. Nothing in this article constitutes guidance on administration, preparation for use, or any clinical, therapeutic, diagnostic or cosmetic application.
